Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Answer to Vieira et al. "Cytokine profile as a prognostic tool in coronavirus disease 2019". Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006.

ABSTRACT:

SUBMITTER: Quartuccio L

PROVIDER: S-EPMC7498467 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Answer to Vieira et al. "Cytokine profile as a prognostic tool in coronavirus disease 2019". Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006.

Quartuccio Luca L Benucci Maurizio M De Vita Salvatore S

Joint bone spine 20200918 1

PMID: 32950703

Similar Datasets

Feng et al 2019 - Microarray Raw Data

Project description:In order to identify mechanisms of drug resistance to HER2-targeted therapy, we performed cDNA microarray analysis on drug naiive BT474 and drug resistant BT474 cells treated with lapatinib for 0, 10, and 20 hrs.

2020-04-14 | GSE136304 | GEO

Corrigendum to Bae et al. J Cachexia Sarcopenia Muscle 11, 1089-1103, 2020. doi: 10.1002/jcsm.12563.

Project description: Not available

| S-EPMC7567145 | biostudies-literature

Discussion of Kallus (2020) and Mo et al (2020).

Project description:We discuss the results on improving the generalizability of individualized treatment rule following the work in Kallus [1] and Mo et al. [5]. We note that the advocated weights in Kallus [1] are connected to the efficient score of the contrast function. We further propose a likelihood-ratio-based method (LR-ITR) to accommodate covariate shifts, and compare it to the CTE-DR-ITR method proposed in Mo et al. [5]. We provide the upper-bound on the risk function of the target population when both the covariate shift and the contrast function shift are present. Numerical studies show that LR-ITR can outperform CTE-DR-ITR when there is only covariate shift.

| S-EPMC8409173 | biostudies-literature

Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.

Project description: Not available

| S-EPMC7357515 | biostudies-literature

Answer to the letter by Frass et al. to our systematic review

Project description: Not available

| S-EPMC9470608 | biostudies-literature

Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on "Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome" by Quartuccio et al. Joint Bone Spine. 2020;87:191-93.

Project description: Not available

| S-EPMC7497797 | biostudies-literature

Answer to Gerber et al. "Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy".

Project description:Gal et al address the issues raised by Gerber et al and reiterate that patients in their study showed decreased Misato homolog 1 (MSTO1) mRNA and protein levels, but also confirm finding of Gerber et al that the mutation is in MSTO2p pseudogene. Whether MSTO2p variant contributes to the observed decrease in MSTO1 levels in patients remains unclear.

| S-EPMC10405052 | biostudies-literature

Harbort&Hashimoto et al. 2020

Project description:Root-secreted coumarins and the microbiota interact to improve iron nutrition in Arabidopsis. Harbort and Hashimoto et al. Cell Host & Microbe 2020

| PRJEB38663 | ENA

Feldman et al. 2019 Nat Comm

Project description:Late Pleistocene human genome suggests a local origin for the first farmers of central Anatolia

| PRJEB24794 | ENA

Feldman et al.,Science Advances, 2019

Project description:Ancient DNA sheds light on the genetic origins of early Iron Age Philistines.

| PRJEB31035 | ENA